On October 11, 2024, Heart Test Laboratories, Inc., a company listed on The Nasdaq Stock Market under the ticker symbols HSCS for its common stock and HSCSW for its warrants, announced a corporate name change to HeartSciences Inc. following approval from its shareholders during the Annual Meeting held on January 17, 2024. The company is currently awaiting confirmation from the Secretary of State of Texas for the name change to take effect at the state level. Once confirmed, Heart Test Laboratories will implement the name change in the market and will make a separate announcement regarding the effective date. The change of corporate name will not affect the ticker symbols or the CUSIP number for the company's public warrants and outstanding shares of...Show More

On October 11, 2024, Heart Test Laboratories, Inc., a company listed on The Nasdaq Stock Market under the ticker symbols HSCS for its common stock and HSCSW for its warrants, announced a corporate name change to HeartSciences Inc. following approval from its shareholders during the Annual Meeting held on January 17, 2024. The company is currently awaiting confirmation from the Secretary of State of Texas for the name change to take effect at the state level. Once confirmed, Heart Test Laboratories will implement the name change in the market and will make a separate announcement regarding the effective date. The change of corporate name will not affect the ticker symbols or the CUSIP number for the company's public warrants and outstanding shares of common stock. Existing public warrants and stock certificates will remain valid and need not be exchanged. The company's Amended and Restated Certificate of Formation will not undergo any changes other than the name change. The Certificate of Amendment has been filed with the SEC and is included as Exhibit 3.1 in the company's Current Report on Form 8-K.